Anti-VEGF: the evidence

This article from our recent issue on non-communicable eye diseases summarises the current Cochrane reviews on the effects of anti-VEGF treatment for age-related macular degeneration (AMD), diabetic macular oedema and safety.

The article looks at the evidence on:

• effects of anti-VEGF on vision
• adverse events
• systemic safety of ranibizumab and bevacizumab
• future research directions

Read the full article: “Anti-VEGF drugs: evidence for effectiveness”